Approval · Notice of Compliance 18416 · 2016
BANAMINE: Notice of Compliance 18416
Issued August 31, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18416
- Date
- August 31, 2016
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BANAMINE | 02457180 | Marketed |
Medicinal ingredients
- FLUNIXIN MEGLUMINE 50 MG per ML